| Name | Title | Contact Details |
|---|
Marathon Health is based in Indianapolis, IN and Winooski, VT. When we say we are a different kind of healthcare company, we mean we`re a better kind. What makes us better is that we guide people to take control of their own health. We operate on a simple premise: when people are given the tools they need to manage their own health and healthcare, the cost of healthcare is lower. We believe the best way to keep people healthy is to help them manage risk factors and chronic conditions, and to keep them from getting sick in the first place. To do this, we combine a powerful collection of onsite health services into a program tailored to your unique culture, setting, and workforce.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
nmc holdings is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
INTEGRIS Health is Oklahoma`s largest health system with hospitals, rehabilitation centers, physician clinics, mental health facilities, independent living centers and home health agencies located throughout the state. INTEGRIS Health is a not-for-profit corporation. It was organized under the laws of the state of Oklahoma for charitable, scientific and educational purposes and specifically to engage in the delivery of health-care services and related activities. INTEGRIS Health is governed by an 11 to 15-member board of directors made up of business and community leaders from across the state. It`s managed by President and Chief Executive Officer Bruce Lawrence, with the assistance of senior staff in the areas of physician services, facility operations, strategic services and finance. INTEGRIS Health is a not-for-profit corporation formed in 1983 to serve as the parent corporation for, and to provide management and administrative support to, INTEGRIS Baptist Medical Center Inc., another Oklahoma not-for-profit corporation that operates a tertiary care hospital in northwest Oklahoma City. In 1994, INTEGRIS Health merged with Baptist Healthcare of Oklahoma, an event that brought to the organization a network of outstanding rural hospitals across the state. In 1995, INTEGRIS Health merged with Southwest Medical Center, an acute-care hospital in southwest Oklahoma City. Each of these organizations brings a rich history of serving Oklahomans. INTEGRIS Health, along with these and a number of other affiliated entities, form the INTEGRIS Health system.